Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.10 (-6.06%)
Spread: 0.10 (6.667%)
Open: 1.65
High: 1.565
Low: 1.475
Prev. Close: 1.65
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec

Mon, 27th Sep 2021 14:17

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

EMIS Group PLC - Leeds, England-based healthcare software company - Names Denise Collis as an additional independent non-executive director. Collis will formally join the board on Friday. Collis is currently non-executive director, chair of the remuneration committee and senior independent director at SThree PLC and non-executive director and chair of the remuneration committee at Smiths News PLC.

----------

Bank of Ireland Group PLC - Dublin-based company - Chief Financial Officer Myles O'Grady steps down to take up a senior finance role in an organisation outside the financial services sector. O'Grady is expected to leave BoI in March 2022 and a process to appoint his successor will now commence. Myles joined BoI in June 2019 as finance director Ireland and was appointed CFO in October 2019 and a member of the board in January 2020.

----------

Empiric Student Property PLC - London-based real estate investment trust - Says Martin Ratchford has been appointed as an independent non-executive director from Friday. Ratchford has held the post of CFO at Frasers Property UK Ltd since June 2018. Empiric also says Jim Prower will resign as a director on the same day as part of a planned succession process.

----------

Fuller, Smith & Turner PLC - London-based brewery - Says Finance Director Adam Councell will step down from his role and from the board on Thursday. Neil Smith will succeed Councell. In order to ensure a smooth handover to Smith, Councell has agreed to provide appropriate support to the business on a consultancy basis until Smith joins the business on November 30.

----------

Powerhouse Energy Group PLC - Bingley, England-based company which is transforming plastics and waste into clean energy - Says Non-Executive Director Allan Vlah will step down at the end of 2021 to concentrate on his other business interests. Powerhouse Energy appoints Keith Riley as a non-executive director with immediate effect. Riley is currently proprietor & chief executive officer of Vismundi Ltd, a consultancy company providing services to the resources and waste management industry.

----------

LSL Property Services PLC - Newcastle, England-based surveying services company - Names James Mack as a non-executive director, with immediate effect. Mack currently serves as CFO & executive director at Barclays Bank UK PLC. James was previously CFO & executive director at Aldermore PLC and Aldermore Group PLC.

----------

Aberdeen Asian Income Fund Ltd - Chelmsford, England-based investment firm - Hires Robert Kirkby as an independent non-executive director with effect from November 1. "Robert is a former advisory partner at KPMG Channel Islands and a fellow of the Institute of Chartered Accountants with a background as a business leader and a track record of establishing a business, growing revenue and building a dynamic team," says Chair Charles Clarke.

----------

Harland & Wolff Group Holdings PLC - Belfast, Northern Ireland-based investment company - Says Clive Richardson, non-executive chair, is stepping down from the board. Richardson's notice period will run until mid-December 2021. Richardson has decided to step down to focus on other activities to which he is already committed, Harland & Wolff says. A formal process to appoint a successor has been initiated and, whilst this progresses, Malcolm Groat, currently chair of the Audit Committee, has been named as interim chair.

----------

Shield Therapeutics PLC - Newcastle, England-based pharmaceutical company - Names Jose Menoyo as vice president & chief medical officer with immediate effect. Prior to joining Shield, Menoyo served as Head of US Medical Affairs at Alexion Pharmaceuticals Inc.

----------

Corcel PLC - London-based natural resource exploration and development company - Names Henry Bellingham as an independent non-executive director, subject the successful conclusion of due diligence procedures. "Henry has a wealth of experience in the natural resources arena, and I am delighted to welcome him to the team at such an exciting time for the business," says Chair James Parsons.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Jan 2021 18:26

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

Read more
21 Jan 2021 20:12

DIRECTOR DEALINGS SUMMARY: New U&I Group CEO Upton Buys Shares

DIRECTOR DEALINGS SUMMARY: New U&I Group CEO Upton Buys Shares

Read more
19 Jan 2021 15:04

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares

Read more
15 Jan 2021 13:11

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue

Read more
14 Dec 2020 16:59

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

Read more
11 Dec 2020 16:40

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own

Read more
19 Oct 2020 17:34

IN BRIEF: Shield Therapeutics Notes Teva Withdrawing Patent Opposition

IN BRIEF: Shield Therapeutics Notes Teva Withdrawing Patent Opposition

Read more
19 Oct 2020 09:12

Shield shares rise as Teva withdraws patent oppositions

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on its opposition proceedings with Teva Pharmaceutical Industries on Monday, confirming that Teva had withdrawn its appeal and opposition over two of Shield's patents.

Read more
16 Sep 2020 11:13

Shield Therapeutics Swings To Profit As It Makes Feraccru Progress

Shield Therapeutics Swings To Profit As It Makes Feraccru Progress

Read more
7 Aug 2020 06:56

IN BRIEF: Shield Therapeutics' Product Offers Alternative For Anaemia

IN BRIEF: Shield Therapeutics' Product Offers Alternative For Anaemia

Read more
16 Jul 2020 21:19

IN BRIEF: Shield Therapeutics Notes PT20 Paper Publication

IN BRIEF: Shield Therapeutics Notes PT20 Paper Publication

Read more
26 Jun 2020 17:19

UK EXECUTIVE CHANGE SUMMARY: John Menzies Chief Executive Steps Down

UK EXECUTIVE CHANGE SUMMARY: John Menzies Chief Executive Steps Down

Read more
11 Jun 2020 16:17

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
3 Jun 2020 15:57

Shield Therapeutics shares rise on two recent research papers

(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics reported the recent publication of two papers concerning its 'Feraccru' or 'Accrufer' product on Wednesday.

Read more
26 May 2020 14:22

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.